Pipeline

Technophage currently holds a well-balanced and diversified product portfolio addressing key therapeutic and non-therapeutic areas while simultaneously being agile in meeting the challenges of the rapidly evolving pharmaceutical industry.

Therapeutic products

Chronic ulcers

DiscoveryPreclinicalIND/CTAPhase IPhase IIPhase III

  • TP-10284%84%

Respiratory infection

  • TP-12252%52%

Urinary tract infection

  • TP-16429%29%

Spinal cord injury

  • TZ-16158.5%58.5%

Undisclosed

  • TP-2513%3%

Undisclosed

  • TC-25520%20%

Non-therapeutic products

Biomarker

DiscoveryPreclinicalClinical

  • TA-111C65%65%

Dietary Supplement

  • C1/PD-00105100%100%

Undisclosed

  • TP-25450%50%

Therapeutic products

Non-therapeutic products